Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-043713

President and COO sold 8,000 shares at an average $13.62 ($108,994)

  • President and COO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Larson Tina Marriott · President and COO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-27 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $1.06 $8,480 432,160 D
2023-07-27 Sale : show line 2 in the form 10b5-1 −3,627 $13.12 $47,570 428,533 D
2023-07-27 Sale : show line 3 in the form 10b5-1 −4,373 $14.05 $61,424 424,160 D
Open-market sales · 8,000 sh · avg $13.62 · $108,994

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-07-29 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −8,000 $1.06 2028-07-22 8,000 532,000 D
Loading xslF345X05/doc4.xml…